Envestnet Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $467K | Buy |
+40,094
| New | +$467K | ﹤0.01% | 3741 |
|
|
2024
Q2 | – | Sell |
-12,120
| Closed | -$38.9K | – | 4164 |
|
|
2024
Q1 | $38.9K | Sell |
12,120
-6,156
| -34% | -$19.8K | ﹤0.01% | 4117 |
|
|
2023
Q4 | $89.6K | Sell |
18,276
-899
| -5% | -$4.41K | ﹤0.01% | 3953 |
|
|
2023
Q3 | $105K | Sell |
19,175
-4,007
| -17% | -$21.8K | ﹤0.01% | 3870 |
|
|
2023
Q2 | $156K | Sell |
23,182
-1,870
| -7% | -$12.5K | ﹤0.01% | 3769 |
|
|
2023
Q1 | $221K | Buy |
25,052
+2,651
| +12% | +$23.4K | ﹤0.01% | 3608 |
|
|
2022
Q4 | $171K | Sell |
22,401
-2,320
| -9% | -$17.7K | ﹤0.01% | 3709 |
|
|
2022
Q3 | $176K | Sell |
24,721
-1,578
| -6% | -$11.2K | ﹤0.01% | 3623 |
|
|
2022
Q2 | $213K | Buy |
26,299
+7,778
| +42% | +$63K | ﹤0.01% | 3554 |
|
|
2022
Q1 | $257K | Sell |
18,521
-27,685
| -60% | -$384K | ﹤0.01% | 3535 |
|
|
2021
Q4 | $1.3M | Buy |
46,206
+985
| +2% | +$27.6K | ﹤0.01% | 2451 |
|
|
2021
Q3 | $1.54M | Buy |
45,221
+164
| +0.4% | +$5.57K | ﹤0.01% | 2267 |
|
|
2021
Q2 | $1.84M | Buy |
45,057
+1,707
| +4% | +$69.7K | ﹤0.01% | 2115 |
|
|
2021
Q1 | $1.75M | Buy |
43,350
+12,972
| +43% | +$522K | ﹤0.01% | 2029 |
|
|
2020
Q4 | $1.8M | Buy |
30,378
+10,145
| +50% | +$600K | ﹤0.01% | 1821 |
|
|
2020
Q3 | $984K | Buy |
20,233
+11,656
| +136% | +$567K | ﹤0.01% | 2023 |
|
|
2020
Q2 | $415K | Buy |
+8,577
| New | +$415K | ﹤0.01% | 2515 |
|